Preview Newsletter
Ethicon Media Monitoring 4/7/2017
-
Medical Study on Chronic Mesh Pain Needs to Hear From You!
Apr 6, 2017 | Mesh Medical Device Newsdesk
People suffering with chronic pain are asked to attend a one-day workshop in the Pittsburgh, Pennsylvania area. -
Trump’s FDA Pick Grilled on Priorities, Conflicts
Apr 6, 2017 | Mesh Medical Device Newsdesk
President Trumps selection of Scott Gottlieb reveals a health industry insider full of potential conflicts.
Client Attorney Privileged/Attorney Work Product/At Request of Counsel
Online Sources
-
Medical Study on Chronic Mesh Pain Needs to Hear From You!
Apr 6, 2017 | Mesh Medical Device Newsdesk
Mesh Medical Device News Desk, April 6, 2017 ~ People suffering with chronic pain are asked to attend a one-day workshop in the Pittsburgh, Pennsylvania area.
Still Standing, a contributor to Mesh News Desk, is involved with a partnership with the University of Maryland and other institutions from around the world to teach researchers in chronic pain what they need to be measuring for outcomes. Chronic mesh pain certainly qualifies.
There is a big gap in research about pain and the ability to translate that to interventions that actually help pain patients. Meetings will bring in people who live with chronic pain to work with scientists who study pain. It is an important step in pain research.
Still Standing will be there and it is part of the American Pain Society annual scientific meeting. There is some money available for a small travel and time stipend. Food and refreshments will be provided. The principle investigator is at the University of Maryland. Her contact information is on the attachment. If any one is interested in attending, they just need to contact her for more details.MAKE YOUR VOICE HEARD!
In order to better understand what researchers should know before engaging in patient centered outcomes research with the chronic pain community, the University of Maryland School of Public Health in collaboration with PAINS and the National Research Council is looking for patients living with chronic pain and their caregivers to invite to a one-day working meeting in Pittsburgh, Pennsylvania on May 17, 2017. The working meeting will be held 10am – 3:30pm in rooms 401/402 of the David L. Lawrence Convention Center in Pittsburgh, Pennsylvania. To facilitate your participation, we can provide a stipend to cover your travel expenses and time, as well as lunch and refreshments during the meeting.
The purpose of this one-day working meeting is to discuss approaches for including community stakeholders in cultural competency/health literacy training for researchers interested in engaging in patient centered outcomes research (PCOR), and the added value of using patients as teaching partners. This working meeting directly addresses the National Pain Strategy which calls for improvements in “discipline-specific core competencies, including basic knowledge, assessment, effective team-based care, empathy, and cultural competency.”
During our meeting, we will review findings from an updated literature review of the role of patients/caregivers in health professional education, as well as findings from focus groups and in-depth interviews with patients living with chronic pain and chronic pain researchers. Most importantly, we will tease out together the key principles of a cultural competency/health literacy curriculum for patient-centered outcomes researchers; recommended evaluation and assessment methods and approaches to measuring patient engagement; and successful models.
If you are willing to give a little of your time to help inform implementation of this important aspect of the National Pain Strategy, please confirm your attendance with Dr. Olivia Carter-Pokras at opokras@umd.edu by April 14, 2017.
http://www.meshmedicaldevicenewsdesk.com/medical-study-chronic-mesh-pain-needs-hear/
-
Trump’s FDA Pick Grilled on Priorities, Conflicts
Apr 6, 2017 | Mesh Medical Device Newsdesk
Mesh Medical Device News Desk, April 6, 2017 ~ President Trumps selection of Scott Gottlieb reveals a health industry insider full of potential conflicts.
Dr. Scott Gottlieb was grilled during a confirmation hearing on Capitol Hill Wednesday and said his first priorities will include the opioid crisis.
Gottlieb is a medical doctor who turned to health consulting for the very industries he would regulate. It is the potential for financial conflicts-of-interest that a Senate health committee must reveal.
The nominee is on the receiving end of thousands of dollars from companies involved in health care. He also receives income from venture capital firms and investment bank involved in funding health care companies, according to the NY Daily News.
If confirmed, Gottlieb says he will recuse himself from decision involving GlaxoSmithKline and about 20 other companies. He would also have to resign his position on the board or as a consultant to nine other health care related companies.
Science will prevail at the agency with him at the head Gottlieb told Senators. As a cancer survivor, he says he understands the important role the FDA plays in public health.
Gottlieb stressed the importance of bringing new products to market, which is the constant criticism by industry of the agency, versus making sure good science guides the FDA in its decision making.
Opioid addiction could be addressed by finding non-addictive alternative painkillers, Gottlieb said.
Gottlieb, 44, was a deputy commission previously under the presidency of George W. Bush.
He currently is a fellow at the American Enterprise Insitute, a conservative nonprofit, from which he would resign. He is a frequent contributor of op-ed articles favoring drug and medical device firms.
But Sen. Patty Murray of Washington, the committee’s senior Democrat, questioned whether recusals are enough to erase the bias of being a pharmaceutical industry insider when dozens of drugs being developed by those companies could come before the FDA.
“I want to earn the public’s trust,” Gottlieb reportedly said.
In other conversations Gottlieb voiced his disagreement with President Trump’s suggestion that vaccines may be linked to autism saying it’s been exhaustively studied and there is no causal link. He said he is committed to tobacco control particularly in adolescents and e-cigarettes.
http://www.meshmedicaldevicenewsdesk.com/trumps-fda-pick-grilled-priorities-conflicts/
Client Attorney Privileged/Attorney Work Product/At Request of Counsel
Online Sources
Add recipients
Suggested